News

The companies have agreed to begin feasibility studies to evaluate how selected Novartis’ proprietary biologics can be delivered into the bloodstream using Rani’s unique route of administration. After

This is the first ANDA for a generic version of dolutegravir, less than two years after FDA approval of Tivicay® (dolutegravir) for sale in the United States. Upon

The submission was made under the company’s existing Investigational New Drug (IND) application. The Phase IIb study of ORMD-0801 for type 2 diabetics is designed to generate ample

BPD is a field that includes cell engineering, continuous processing, formulation and analytical science, to support development of potential new therapies. The research collaboration will see MedImmune and

Kanuma would be the first approved therapy for these patients if it secures approval from the Ministry. The NDA was based on data from the global, randomized, double-blind,

ZS-9 is an insoluble, non-absorbed zirconium silicate and it has a clearly defined three-dimensional crystalline lattice structure that was designed and engineered to preferentially trap potassium ions. The

The company is developing PRX302 (topsalysin) for the treatment of urological diseases. Around 20 patients will be enrolled in this trial, in which previously secured multi-parametric magnetic resonance

The company said that Stiolto Respimat (tiotropium bromide and olodaterol) is not indicated to treat asthma or acute deterioration of COPD, which is a serious but treatable lung

EastGate is aimed at using drug delivery innovations in the development of improved new formulations and alternative dosage forms of existing biologically active molecules. E-drops has been successfully